|
|
| (11) | Number of the document | C 1265862 |
| (68) | Number of the document | 1265862 |
| (21) | Application number for Supplementary Protection Certificate | PA 2016 013 |
| (22) | Date of filing the application | 2016-05-04 |
| (41) | Date of publication of the application | 2016-05-25 |
| Date of publication of SPC | 2017-06-12 | |
| (24) | Date of coming into effect of SPC | 2021-02-22 |
| (71) |
UCB Biopharma SRL,
Allée de la Recherche 60, 1070 Brussels,
BE
|
| (73) |
UCB Biopharma SRL,
Allée de la Recherche 60, 1070 Brussels,
BE
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (93) | EU/1/15/1073, 2016-01-14 |
| (94) | 2026-02-21 |
| (95) | Brivaracetamas |
| Request filed | SPC extension granted until | Request refused | |
| 2023-06-26 | 2026-08-21 |
| Payment date | Validity (years) | Amount | |
| 2025-01-20 | 5 | 347.00 EUR |
| SPC term extension granted |